Cipla Limited

Cipla Limited is a leading Indian multinational pharmaceutical company dedicated to providing affordable and high-quality medicines worldwide. Established in 1935 by Dr. K.A. Hamied, Cipla has grown into a global healthcare brand with a strong presence in over 80 countries.

Company Overview

• Headquarters: Mumbai, Maharashtra, India

• Industry: Pharmaceuticals & Healthcare

• Global Operations: Asia, Africa, Europe, North America

• Employees: 25,000+

• Core Philosophy: Caring for Life

Key Business Segments

Cipla focuses on major therapeutic areas such as:

• Respiratory Care (Asthma, COPD)

• Cardiology

• Diabetes

• Oncology

• HIV/AIDS

• Anti-infectives

Global Recognition

Cipla is globally recognized for making life-saving HIV/AIDS medicines affordable, significantly impacting healthcare accessibility in developing countries.

Research & Innovation

The company invests heavily in:

• Advanced drug delivery systems

• API (Active Pharmaceutical Ingredients) manufacturing

• Biosimilars & specialty medicines

• Sustainable pharmaceutical practices

Commitment

Cipla Limited continues to strengthen its mission of delivering accessible, affordable, and innovative healthcare solutions to millions of patients worldwide.